Portfolio Solutions’s NeoGenomics NEO Stock Holding History

Portfolio Solutions’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-665	Closed	-$5K	–	130
2018 Q1	$5K	Hold	665	–	–	﹤0.01%	167
2017 Q4	$6K	Hold	665	–	–	﹤0.01%	149
2017 Q3	$7K	Hold	665	–	–	﹤0.01%	138
2017 Q2	$6K	Hold	665	–	–	﹤0.01%	137
2017 Q1	$5K	Buy	+665	New	+$5.42K	﹤0.01%	168

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Portfolio Solutions's NEO Position: Q2 2018 in Review

Portfolio Solutions sold out of NeoGenomics (NEO) in Q2 2018, closing a stake of 665 shares — an estimated $5K sold.

Portfolio Solutions first reported a position in NEO in Q1 2017 and held it in 5 quarters. The position peaked at $7K in Q3 2017. 147 funds tracked by Wall St. Rank hold NEO as of Q2 2018.

Portfolio Solutions reported no remaining NeoGenomics position as of Q2 2018 after selling out during the quarter.
Portfolio Solutions sold 665 NeoGenomics shares in Q2 2018, an estimated $5K.
Portfolio Solutions first reported a position in NeoGenomics in Q1 2017 and held it in 5 quarters.
Portfolio Solutions's NeoGenomics position peaked at $7K in Q3 2017.
147 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2018.

Based on Portfolio Solutions's 13F filing for Q2 2018, filed 13 Jul 2018.